PURPOSE: Although speech motor changes are reported as a common sign of Huntington's disease (HD), the most prominent signs of voice dysfunction remain unknown. The aim of the current study was to explore specific changes in phonatory function in subjects with HD. METHOD: 34 subjects with HD and 34 age- and sex-matched healthy controls were examined. Participants performed sustained vowel phonation for subsequent analyses of airflow insufficiency, aperiodicity, irregular vibrations of vocal folds, signal perturbations, increased noise, and articulation deficiency. In total, 272 phonations were collected and 12 voice parameters were extracted. Subsequently, a predictive model was built to find the most salient patterns of voice disorders in HD. The results were also correlated with disease severity according to the Unified HD Rating Scale (UHDRS) motor score. RESULTS: Subjects with HD showed deterioration in all investigated phonatory functions. Irregular pitch fluctuations, sudden phonation interruption, increased noise, and misplacement of articulators were found to be most significant patterns of phonatory dysfunction in HD (p<0.001). The combination of these four dysphonia aspects contributed to the best classification performance of 94.1% (sensitivity: 95.1%; specificity: 93.2%) in the separation of HD patients from healthy participants. Our results further indicated stronger associations between sudden phonation interruption and voluntary components of the UHDRS (r = -0.48, p<0.01) and between misplacement of articulators and involuntary components of the UHDRS (r = 0.52, p<0.01). CONCLUSIONS: Our configuration of phonatory features can detect subtle voice abnormalities in subjects with HD. As impairment of phonatory function in HD was found to parallel increasing motor involvement, a qualitative description of voice dysfunction may be helpful to gain better insight into the pathophysiology of the vocal mechanism.

Department of Circuit Theory Czech Technical University Prague Faculty of Electrical Engineering Prague Czech Republic

Erratum v

PLoS One. 2013;8(9). doi:10.1371/annotation/a1ee87ea-1fdb-4baa-a8b0-62a44342f3cc PubMed

Zobrazit více v PubMed

Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, et al. (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306: 234–238. PubMed

Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, et al. (1994) A worldwide study of the Huntington's disease mutation: The sensitivity and specificity of measuring CAG repeats. New Engl J Med 330: 1401–1406. PubMed

Hayden MR (1981) Huntington's chorea. New York, Springer-Verlag, 59–92.

Duffy JR (2005) Motor Speech Disorders: Substrates, Differential Diagnosis and Management, 2nd ed., Mosby, New York, p. 592.

Darley FL, Aronson AE, Brown JR (1969) Differential diagnostic patterns of dysarthria. J Speech Hear Res 12: 246–269. PubMed

Ramig LA (1986) Acoustic analysis of phonation in patients with Huntington's disease. Preliminary report. Ann Otol Rhinol Laryngol 95: 288–293. PubMed

Velasco Garcia MJ, Cobeta I, Martin G, Alonso-Navarro H, Jimenez-Jimenez FJ (2011) Acoustic analysis of voice in Huntington's disease. J Voice 25: 208–217. PubMed

Hartelius L, Carlstedt A, Ytterberg M, Lillvik M, Laakso K (2003) Speech disorders in mild and moderate Huntington's disease: Results of dysarthria assessment of 19 individuals. J Med Speech-Lang Pa 1: 1–14.

Zwirner P, Murry T, Woodson GE (1991) Phonatory function of neurologically impaired patients. J Commun Disord 24: 287–300. PubMed

Vogel AP, Shirbin C, Andrew J, Churchyard AJ, Stout JC (2012) Speech acoustic markers of early stage and prodromal Huntington disease: A marker of disease onset? Neuropsychologia 50: 3273–3278. PubMed

Kaploun LR, Saxman JH, Wasserman P, Marder K (2011) Acoustic analysis of voice and speech characteristics in presymptomatic gene carriers of Huntington's disease: Biomarkers for preclinical sign onset? J Med Speech-Lang Pa 19: 49–63.

Tabrizi SJ, Scahill RI, Durr A, Ross RA, Leavitt BR, et al. (2011) Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10: 31–42. PubMed

Huntington Study Group (1996) Unified Huntington's Disease Rating Scale: reliability and consistency. Movement Disord 11: 136–142. PubMed

Rusz J, Cmejla R, Ruzickova H, Ruzicka E (2011) Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson’s disease. J Acoust Soc Am 129: 350–369. PubMed

Boersma P, Weenink D (2001) PRAAT, a system for doing phonetics by computer. Glot International 5: 341–345.

Little MA, McSharry PE, Roberts SJ, Costello DA, Moroz IM (2007) Exploiting Nonlinear recurrence and Fractal scaling properties for voice disorder detection. Biomedical Engineering Online 6: 23. PubMed PMC

Little MA, McSharry PE, Hunter EJ, Spielman J, Ramig LO (2009) Suitability of dysphonia measurement for telemonitoring of Parkinson’s disease. IEEE Trans Biomed Eng 56: 1015–1022. PubMed PMC

Brookes M (2009) VOICEBOX, Speech Processing Toolbox for Matlab, Department of Electrical & Electronic Engineering, Imperial College.

Fraile R, Saenz-Lechon N, Godino-Llorente JI, Osma-Ruiz V, Fredouille C (2009) Automatic detection of laryngeal pathologies in records of sustained vowels by means of mel-frequency cepstral coefficient parameters and differentiation of patients by sex. Folia Phoniatr Logo 61: 146–152. PubMed

Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, et al. (2000) Rate of functional decline in Huntington's disease. Huntington study group. Neurology 54: 452–458. PubMed

Klempir J, Klempirova O, Stochl J, Spackova N, Roth J (2009) The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease. J Neurol 256: 1629–1633. PubMed

Hastie T, Tibshirani R, Friedman JH (2001) The elements of statistical learning: data mining, inference, and prediction: with 200 full-colour illustrations. New York: Springer.

Hertrich I, Ackerman H (1993) Acoustic analysis of speech prosody in Huntington's and Parkinson's disease: a preliminary report. Clin Linguist Phon 7: 285–297.

Ramig LA, Scherer R (1988) Acoustic analysis of voice of patients with neurological disease: rationale and preliminary data. Ann Otol Rhinol Laryngol 97: 164–172. PubMed

Penney JB Jr, Young AB, Shoulson I, Starosta-Rubenstein S, Snodgrass SR, et al. (1990) Huntington’s disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Movement Disord 5: 93–99. PubMed

Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, et al. (2000) Subtle changes among presymptomatic carriers of the Huntington’s disease gene. J Neurol Neurosurg Psychiatry 69: 773–779. PubMed PMC

Lemay M, Chouinard S, Richer F, Lesperance P (2008) Huntington’s disease affects movement termination. Behav Brain Res 187: 153–158. PubMed

Berardelli A, Noth J, Thompson PD, Bollen EL, Curra A, et al. (1999) Pathophysiology of chorea and bradykinesia in Huntington’s disease. Movement Disord 14: 398–403. PubMed

Skodda S, Gronheit W, Schlegel U (2012) Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS One 7: e32132. PubMed PMC

Skodda S (2012) Analysis of voice and speech performance in Parkinson’s disease: a promising tool for the monitoring of disease progression and differential diagnosis. Neurodegen Dis Manage 2: 535–545.

McNeil MR (1997) Clinical management of sensomotoric speech disorders. Thieme, New York.

Kent RD, Kent JF, Duffy JR, Thomas JE, Weismer G, et al. (2000) Ataxic dysarthria. J Speech Lang Hear Res 43: 1275–1289. PubMed

Tsanas A, Little MA, McSharry PE, Spielman J, Ramig LO (2012) Novel speech signal processing algorithms for high-accuracy classification of Parkinson’s disease. IEEE T Bio-Med Eng 5: 1264–1271. PubMed

Rusz J, Cmejla R, Ruzickova H, Klemir J, Majerova V, et al. (2011) Acoustic assessment of voice and speech disorders in Parkinson's disease through quick vocal test. Movement Disord 26: 1951–1952. PubMed

Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY (2012) How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 135: 1860–1870. PubMed

Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, et al. (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25: 1–14. PubMed PMC

Coleman R, Anderson D, Lovrien E (1990) Oral motor dysfunction in individuals at risk of Huntington disease. Am J Med Genet 37: 36–39. PubMed

Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson's disease and Huntington's disease

Automatic Evaluation of Speech Rhythm Instability and Acceleration in Dysarthrias Associated with Basal Ganglia Dysfunction

Characteristics and occurrence of speech impairment in Huntington's disease: possible influence of antipsychotic medication

Phonatory dysfunction as a preclinical symptom of Huntington disease

A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse